REGENXBIO INC's ticker is RGNX and the CUSIP is 75901B107. A total of 172 filers reported holding REGENXBIO INC in Q2 2021. The put-call ratio across all filers is 0.22 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $23,240 | -58.6% | 1,229 | -50.3% | 0.01% | -63.2% |
| Q4 2022 | $56,133 | -45.5% | 2,475 | -36.4% | 0.02% | -62.7% |
| Q3 2022 | $103,000 | +255.2% | 3,893 | +227.4% | 0.05% | +183.3% |
| Q2 2022 | $29,000 | +20.8% | 1,189 | +62.0% | 0.02% | +50.0% |
| Q1 2022 | $24,000 | +50.0% | 734 | +50.7% | 0.01% | +71.4% |
| Q4 2021 | $16,000 | -11.1% | 487 | +16.5% | 0.01% | -41.7% |
| Q3 2021 | $18,000 | -35.7% | 418 | -41.6% | 0.01% | -33.3% |
| Q2 2021 | $28,000 | +211.1% | 716 | +178.6% | 0.02% | +20.0% |
| Q1 2021 | $9,000 | – | 257 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Aquilo Capital Management, LLC | 847,424 | $13,948,599 | 12.64% |
| Sonic GP LLC | 518,079 | $8,527,580 | 8.28% |
| MPM BioImpact LLC | 656,718 | $10,809,578 | 2.89% |
| Redmile Group, LLC | 2,574,042 | $42,368,731 | 2.02% |
| ArchPoint Investors | 224,278 | $3,691,616 | 1.41% |
| WS MANAGEMENT LLLP | 618,131 | $10,174,436 | 0.82% |
| Redwood Wealth Management Group, LLC | 14,360 | $236,366 | 0.28% |
| HARBOR CAPITAL ADVISORS, INC. | 48,559 | $799,281 | 0.17% |
| PRENTISS SMITH & CO INC | 11,240 | $185,010 | 0.14% |
| LIBERTY ONE INVESTMENT MANAGEMENT, LLC | 36,522 | $601,152 | 0.09% |